Linagliptin clinical trials insulin secretagogues

BI-1356 - BI1356 - BI 1356 - Tradjenta - Linagliptin

Diabetes type 2

All type of patients:   pinterest powerpoint 12016,12062,12017,12055,12054,12019,12018,12060,12057,12056,13354,13334,12065,12052

All types of patients:   pinterest powerpoint 12016,12018,12055,12054,12056,12057,12060,12052,12062,12019,13334,12017,13354,12065

Drug naïve patients:   pinterest powerpoint 12019

Patients inadequately controlled on MET+SU therapy :   pinterest powerpoint 12018

Patients inadequately controlled on metformin:   pinterest powerpoint 12056,12062,12055

Patients inadequately controlled on monotherapy :   pinterest powerpoint 12017,12055,12056,12062

Patients inadequately controlled on TZD:   pinterest powerpoint 12054

Patients insufficiently controlled on SU:   pinterest powerpoint 12017

Patients with insufficient glycaemic control with bitherapy:   pinterest powerpoint 12018,12054